| Patents for C07C 237 - Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups (16,118) |
|---|
| 09/26/2002 | WO2002074731A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/26/2002 | WO2002074719A2 Inhibitors of plasmepsins |
| 09/26/2002 | US20020137968 Treating with amides, ureas, amidines, carbamates, carboximidamides and other derivatives of given formula, e.g. (+)-N-((2,2-dimethylcyclopentyl)methyl)-4-hexyloxybenzamide |
| 09/26/2002 | US20020137941 Bicyclic signal transduction inhibitors, compositions containing them & uses thereof |
| 09/26/2002 | US20020137027 Using optical indicator |
| 09/26/2002 | CA2445754A1 3-(2,5-diaminophenyl)-acrylamide derivatives and colouring agents containing said compounds |
| 09/25/2002 | EP1242365A1 Acyl pseudodipeptides which carry a functionalised auxiliary arm |
| 09/25/2002 | EP1242364A1 Adamantane derivatives |
| 09/25/2002 | EP1242363A2 Cd45 inhibitors |
| 09/25/2002 | EP1242360A2 Exciplexes |
| 09/25/2002 | EP0968179B1 N-sulphonyl and n-sulphinyl amino acid amides as microbiocides |
| 09/25/2002 | EP0923550B1 Acylaminoalkenylene-amide derivatives as nk1 and nk2 antagonists |
| 09/25/2002 | CN1371356A Enatiomerically-enriched compounds having photocleavable bond(s) and methods related thereto |
| 09/24/2002 | US6455734 Antagonists of the magnesium binding defect as therapeutic agents and methods for treatment of abnormal physiological states |
| 09/24/2002 | US6455550 N-alkanoylphenylalanine derivatives |
| 09/24/2002 | US6455519 Use of substituted N, N-disubstituted fused-heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/19/2002 | WO2002072545A2 9-aminoacyl tetracycline compounds and methods of use thereof |
| 09/19/2002 | WO2002072534A2 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 09/19/2002 | WO2002072532A1 7, 9-substituted tetracycline compounds |
| 09/19/2002 | WO2002072068A2 Lipids, lipid compositions, liposomes, and lipoplexes |
| 09/19/2002 | WO2001007020A3 Carboxylic acid amides, medicaments containing these compounds and the use and production thereof |
| 09/19/2002 | US20020132849 2-Amino-2-alkyl-5 heptenoic and heptynoic acid derivatives useful as nitric oxide synthase inhibitors |
| 09/19/2002 | US20020132833 Caspase inhibitors and uses thereof |
| 09/19/2002 | US20020132798 7-phenyl-substituted tetracycline compounds |
| 09/19/2002 | US20020132766 Design, preparation, and properties of antibacterial beta-peptides |
| 09/19/2002 | DE10113027A1 3-Diaminophenyl-acrylamide derivatives or their physiologically acceptable, water-soluble salts, used as developers in combination with couplers in oxidative dye formulations, especially for dyeing hair are new |
| 09/19/2002 | DE10058461A1 Substituierte Cyclohexanderivate und ihre Verwendung Substituted cyclohexane derivatives and their use |
| 09/19/2002 | CA2458479A1 1-butane acid derivatives, pharmaceutical compositions containing said derivatives and the use thereof |
| 09/18/2002 | EP1241160A1 Tetracycline derivatives and their use as antibiotic agents |
| 09/18/2002 | EP1240154A1 Serine protease inhibitors |
| 09/18/2002 | EP1240133A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 09/18/2002 | EP1240132A1 Adamantane derivatives |
| 09/18/2002 | EP1036059B1 Adamantane derivatives |
| 09/18/2002 | EP0901460B1 A process for the preparation of 5-amino-2,4,6-triiodo-1,3-benzenedicarboxylic acid derivatives |
| 09/18/2002 | EP0804427B1 Lta4 hydrolase inhibitors |
| 09/18/2002 | CN1370161A Novel quaternary ammonium compounds, its prepn. methods and medicinal application |
| 09/17/2002 | US6451830 Use of substituted N,N-disubstituted non-fused heterocyclo amino compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | US6451823 Use of substituted N-phenoxy-N-phenyl aminoalcohol compounds for inhibiting cholesteryl ester transfer protein activity |
| 09/17/2002 | CA2278878C Very large scale immobilized peptide synthesis |
| 09/12/2002 | WO2002070493A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/12/2002 | WO2002070492A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 09/12/2002 | WO2002070473A2 Carboxamide derivatives as therapeutic agents |
| 09/12/2002 | WO2002070471A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | WO2002050100A3 Diaminodicarboxylic acid: peptide-based gemini surfactant compounds used for drug delivery |
| 09/12/2002 | WO2002050077A3 Triazolopyrimidines |
| 09/12/2002 | US20020128511 Catalytic hydrogenolysis of a 2-dibenzylamino-N-(2-(2',5'-dimethoxyphenyl)-2-hydroxyethyl)acetamide formed by reacting a dibenzylamine and chloro-N-(2-(2',5'-dimethoxyphenyl)-2-hydroxyethyl)acetamide; nonexplosive |
| 09/12/2002 | US20020128269 Piperazine derivatives |
| 09/12/2002 | US20020128266 ABCA-1 elevating compounds |
| 09/12/2002 | US20020128255 Substituted hydroxyl amine derivatives; inhibitors of beta-secretase, inhibit beta-secretase-mediated cleavage, inhibitors of A beta production, and/or are effective to reduce amyloid beta deposits or plaques |
| 09/12/2002 | US20020128238 7-phenyl-substituted tetracycline compounds |
| 09/12/2002 | US20020128237 7-N-substituted phenyl tetracycline compounds |
| 09/12/2002 | US20020127202 Compounds and compositions for delivering active agents |
| 09/12/2002 | DE10111392A1 Bioanalytisches Messverfahren unter Verwendung von Oxidasen Bioanalytical measurement methods using oxidases |
| 09/12/2002 | CA2440104A1 New asymmetric process for the preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 09/12/2002 | CA2439644A1 Phenyl derivatives and their use in the treatment of thromboembolic disorders or tumours |
| 09/12/2002 | CA2434184A1 Bisaryl derivatives having fsh receptor modulatory activity |
| 09/11/2002 | EP1239049A2 Hydrogen peroxide determination using oxidases and lanthanoide-ligand complexes |
| 09/11/2002 | EP1238966A2 Hair cosmetic, aminocarboxylic acid amide and method for producing the same |
| 09/11/2002 | EP1237872A1 Compounds and compositions for delivering active agents |
| 09/11/2002 | EP1237849A1 Activators of soluble guanylate cyclase |
| 09/11/2002 | EP0912504B1 Oxazolidine ester |
| 09/11/2002 | EP0809519B1 Compositions comprising tricodobenzene polymers for imaging the gastrointestinal tract |
| 09/11/2002 | EP0769942B1 Use of a cationic amphipathic compound as a transfection agent, vaccine additive or drug |
| 09/11/2002 | CN1368954A Salicylamide derivatives |
| 09/11/2002 | CN1090637C Cross-link cinnamic acid derivative and its preparation method |
| 09/10/2002 | US6448443 Synthesis of combinatorial libraries of compounds reminiscent of natural products |
| 09/10/2002 | US6448442 Contrast media |
| 09/10/2002 | US6448373 Inhibitors of enzymes such as phospholipase a2; treatment of inflammatory diseases including atopic dermatitis and inflammatory bowel disease |
| 09/10/2002 | US6448295 Treating cardiovascular disease; atherosclerosis, dyslipidema hypercholesterolaemia; decreasing concentrations of low density lipoprotein and raising level of high density lipoprotein |
| 09/10/2002 | US6448293 Treatment or prevention of a disorder in which the regulation of monoamine transporter function is implicated, such as premature ejaculation. |
| 09/10/2002 | US6448277 VEGF receptor tyrosine kinase inhibitors |
| 09/10/2002 | US6448254 Substituted amides, their production and their use |
| 09/06/2002 | WO2002068592A2 Non-racemic hexafluoreleucine, and methods of making and using it |
| 09/06/2002 | WO2002068380A1 Synthetic excitatory amino acids |
| 09/06/2002 | WO2002068377A1 Omega-aminoalkylamides of r-2-aryl-propionic acids as inhibitors of the chemotaxis of polymorphonucleate and mononucleate cells |
| 09/06/2002 | WO2002067919A1 Il-8 receptor antagonists |
| 09/06/2002 | WO2002067918A1 Novel diallylmethylamine derivative |
| 09/06/2002 | WO2002032868A3 2-substituted heterocyclic compounds and their use in treating multidrug resistance |
| 09/05/2002 | US20020123637 Pharmaceutically active compounds and methods of use thereof |
| 09/05/2002 | US20020123528 Alkynyl amides and their therapeutic applications |
| 09/05/2002 | US20020123527 Administering a 2-hydroxy-4-oxo- or 4,6-dioxo-6-pheny-l or naphthyl- hex-2-enoic acid; viricides; AIDS/ARC |
| 09/05/2002 | US20020123498 For inhibiting transport protein; therapy |
| 09/05/2002 | DE10110325A1 Phenylderivate 2 Phenyl derivatives 2 |
| 09/04/2002 | EP1235789A2 $g(b)-AMINOACID COMPOUNDS USEFUL FOR INHIBITING $g(b)-AMYLOID PEPTIDE RELEASE AND/OR ITS SYNTHESIS |
| 09/04/2002 | EP1235788A1 Process for the preparation of arylethanolamine derivatives having an anti-obesity and anti-diabetic properties |
| 09/04/2002 | EP1235786A2 Method for the preparation of enantiomerically enriched compounds |
| 09/04/2002 | EP1235765A2 Systems and methods to facilitate multiple order combinatorial chemical processes |
| 09/04/2002 | EP0883602B1 Lipids |
| 09/03/2002 | US6444851 Process for the preparation of Midodrine |
| 09/03/2002 | US6444849 Amide derivatives |
| 09/03/2002 | US6444816 Dietetics, anticholesterol agents, antidiabetic agents |
| 08/29/2002 | WO1999064055A9 Multivalent agonists, partial agonists, inverse agonists and antagonists of the 5ht4 receptors |
| 08/29/2002 | US20020120148 Benzocycloheptenylamino derivatives; treatment of pollakiuria or urinary incontinence |
| 08/29/2002 | US20020120137 FXR modulators |
| 08/29/2002 | US20020120096 Capable of stably fixing a water-soluble polymer onto a surface structure by taking advantage of intermolecular interaction, thereby enabling the water-soluble polymer to be carried thereon without giving any damage |
| 08/29/2002 | US20020120011 Substituted N, N-disubstituted diamino compounds useful for inhibiting cholesteryl ester transfer protein activity |
| 08/29/2002 | US20020120009 Compounds and compositions for delivering active agents |
| 08/29/2002 | US20020120007 Benzamide inhibitors of factor Xa |
| 08/29/2002 | US20020119992 Anticoagulants |
| 08/29/2002 | US20020119979 Cancer therapy |